Latest clinical investigator Stories

2014-04-23 12:30:25

Program Will Drive Research Collaboration, Enhance Site Sustainability ELLICOTT CITY, Md., April 23, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) is proud to announce the launch of its newest initiative, the Site Advocacy Group (SAG). SCRS is honored to have TransCelerate BioPharma Inc. ("TransCelerate") as its SAG partner. The SAG is a landmark industry initiative that enables clinical investigators and site professionals to interact directly with senior...

2013-10-01 23:28:26

Xtalks presents an exciting live webinar on Thursday, October 10, 2013, at 11:00am EDT. Join keynote speaker Mark Travers, Vice President and Head of Sanofi-Aventis’s Clinical Study Unit, for a one-hour discussion on current developments in risk-based monitoring. Toronto, Canada (PRWEB) October 01, 2013 Effective monitoring of clinical investigations is critical to the protection of human subjects and the conduct of high-quality studies. Clinical investigations involving human drugs,...

2011-07-25 08:44:00

Report available for public review and comment SILVER SPRING, Md., July 25, 2011 /PRNewswire-USNewswire/ -- A U.S. Food and Drug Administration report from its Center for Drug Evaluation and Research (CDER), available today in the Federal Register, identifies the current regulatory science needs that will guide CDER's strategic planning of internal research initiatives and contributions to the development of agency regulatory science efforts. (Logo:...

2010-03-02 07:00:00

SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced the appointment of Peter K. Honig, MD, MPH to its board of directors. Dr. Honig brings over 20 years of clinical and regulatory policy experience from past roles with Merck & Company and the U.S. Food and Drug Administration (FDA). Most recently, he was Senior Vice President of Worldwide Regulatory...

2009-04-23 08:30:00

Conference Features Renowned Translational Cancer Researchers and Updates on Key Discoveries, Plus Panel Discussion with Academic and Industry Leaders NEW YORK, April 23 /PRNewswire-USNewswire/ -- Internationally renowned physician-scientists will discuss the rapidly changing cancer research landscape in the US, plus important recent discoveries in translational cancer research, during the first Damon Runyon Cancer Research Foundation Clinical Investigator Symposium. The April 27th event,...

2009-04-14 14:45:25

The U.S Food and Drug Administration says Coast IRB LLC of Colorado Springs has agreed to halt some aspects of its clinical trial oversight operations. The FDA said the action stems from serious concerns about the institutional review board company's ability to protect human subjects participating in clinical trials. The FDA said company records indicate the suspension of activities could involve approximately 300 active human research studies conducted by some 3,000 clinical investigators....

Word of the Day
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'